Why RE/MAX (RMAX) Stock Is Up Today

RE/MAX (RMAX) shares rose after the DOJ granted early termination of the HSR waiting period for its proposed merger with The Real Brokerage, removing a key antitrust review hurdle. The deal still requires shareholder approvals. RMAX closed at $10.71, up 0.9% on the day.

Original reporting
Published Jul 14, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 14, 2026, 9:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why RE/MAX (RMAX) Stock Is Up Today — source image
Decision brief

The 30-second read

$RMAXBullishMed
01

Why it matters

Clearing the HSR waiting period reduces regulatory uncertainty and can tighten spreads for merger-related positioning, but the transaction still requires shareholder approvals to close.

02

Market read

A concrete antitrust milestone likely increases perceived deal completion probability, explaining the same-day jump in RMAX.

03

What to watch

The article does not quantify deal economics or timing; traders may be over-weighting the regulatory milestone versus remaining approval and integration risks.

Relevance 8/10Novelty 7/10Timing: Afternoon session move tied to same-day DOJ HSR early termination news.

Background

HSR requires antitrust notification and a waiting period for large mergers; early termination indicates regulators see no major issues at that stage.

Company-level read

Ticker impact

$RMAXBullishMedium confidence
Context

RE/MAX shares rose after the DOJ granted early termination of the HSR waiting period for its proposed merger with The Real Brokerage.

Expected impact

Near-term upside bias while traders price higher probability of deal closing; volatility likely persists until shareholder votes and final regulatory steps.

Evidence & confidence

The article cites a concrete regulatory milestone (HSR early termination) that typically reduces deal risk, yet explicitly notes the merger is not final and still requires shareholder approvals.

Market effects

Supports sentiment for rate-sensitive real estate and franchise-adjacent names, though the article’s main catalyst is deal-specific.

No specific regional impact described beyond general housing-rate read-through.

No direct global linkage beyond the article’s broader macro discussion of yields and oil.

Counterpoint

HSR early termination may not eliminate other closing risks, so the stock could retrace if shareholder approvals or other conditions face delays.

Key entities

  • RE/MAX

    Real estate franchise company whose proposed merger received DOJ HSR early termination.

  • The Real Brokerage

    Counterparty in RE/MAX’s proposed merger referenced in the HSR early termination decision.

  • Department of Justice

    Granted early termination of the HSR waiting period for the proposed merger.

Related articles

$RMAXMed

RE/MAX (NYSE:RMAX) Misses Q2 CY2026 Sales Expectations

RE/MAX (NYSE:RMAX) reported Q2 CY2026 results that missed Wall Street expectations. Revenue fell 5.8% year on year to $68.51 million, and non-GAAP adjusted EPS was $0.32, down from $0.39 and 18.6% below consensus. Analysts expect revenue to rise 3.3% and full-year EPS to increase from $1.15 to $1.33.

$RMAXMedAI 8/10

RE/MAX HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS

RE/MAX Holdings (NYSE: RMAX) reported Q2 2026 revenue of $68.5M, down 5.8% year over year, and adjusted EBITDA of $22.9M, down 12.6%. GAAP net loss was $4.3M, or -$0.20 per diluted share. The company also disclosed a planned merger with The Real Brokerage, offering Real REMAX Group shares or $13.80 cash per RMAX share, expected to close in H2 2026.

$RMAXMed

RE/MAX Holdings, Inc. (RMAX): Results of Operations and Financial Condition

RE/MAX Holdings, Inc. (RMAX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622438d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 RE/MAX HOLDINGS, INC. REPORTS SECOND QUARTER 2026 RESULTS Total Second Quarter Revenue of $68.5 Million, Adjusted EBITDA of $22.9 Million DENVER, August 6, 2026 Second Quarter 2026 Highlights (Compared to second quarter 2

$RMAXMedAI 8/10

Real-REMAX Deal Clears DOJ and FTC Scrutiny

Real’s SEC filing says the DOJ granted early termination of the antitrust waiting period for Real’s $880 million bid to buy RE/MAX. The FTC says early termination occurs only after both agencies complete review and plan no enforcement during the period. Shareholder approval is set for Aug. 14. Real shares rose about 4% after the filing.

$RKLBMedAI 8/10

Rocket Lab (RKLB) Won a Major Space Force Contract. Now It Has to Prove Neutron

Rocket Lab (NASDAQ:RKLB) said Aug. 4 it won a $397 million U.S. Space Force contract under the SB-AMTI program to develop, launch and operate Flatellite satellites for airborne target tracking. The work depends on Rocket Lab’s Neutron rocket, whose first flight has been delayed to late 2026 after a Stage 1 tank failure. Rocket Lab reported Q1 FY2026 revenue of $200.3 million.

$DVHighAI 9/10

DoubleVerify Shares Rally After Nielsen Agrees to $2.15 Billion Takeover

DoubleVerify (NYSE:DV) shares rose about 13.6% premarket after Nielsen Holdings agreed to buy DV in an all-cash deal valued at about $2.15 billion. DV shareholders will receive $13.60 per share, a 30% premium to the 60-day VWAP. The boards approved; closing is expected in Q1 2027. Several brokerages cut ratings to Hold/Market Perform with targets at $13.60.